Equities

Manuka Inc

MNKA:PKL

Manuka Inc

Actions
  • Price (USD)0.03
  • Today's Change0.00 / 0.00%
  • Shares traded-1.00
  • 1 Year change-98.41%
  • Beta-1.7609
Data delayed at least 15 minutes, as of May 09 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Manuka, Inc., formerly Artemis Therapeutics, Inc., is focused on offering facial skincare products based on Manuka honey and bee venom. The Company’s products include Face Serum with Manuka Honey and Bee Venom, Face Serum with Enhanced Vitamin C, Day Cream, Nourishing Night Cream with Manuka Honey and Nee Venom, Eye Cream with Manuka Honey and Bee Venom, Face Cleanser Gel and Face Serum. Its Face Serum with Manuka Honey and Bee Venom supports blurring and reduces skin wrinkles. It regenerates skin cells and gives a young and vital appearance to the skin. The bee venom encourages natural skin revival, boosts production of Collagen, enhances skin elasticity and has healing properties for damages skin cells.

  • Revenue in USD (TTM)671.00k
  • Net income in USD-1.14m
  • Incorporated2003
  • Employees4.00
  • Location
    Manuka Inc3 Eliezer Vardinon St.PETAH TIKVA 4959507IsraelISR
  • Phone+1 6 462331454
  • Fax+1 3 026555049
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Axim Biotechnologies Inc39.77k-8.06m3.10m6.00------78.05-0.0366-0.03660.0001-0.03110.0095----6,628.33-193.43-154.34---390.73-----20,265.75-36,362.71---0.62----345.05-27.38-29.10------
Eiger Biopharmaceuticals Inc15.77m-74.96m3.11m25.00------0.1972-50.80-50.8010.69-9.770.19850.00649.19630,920.00-94.31-60.25-186.10-76.5199.91---475.26-823.590.6809-22.031.54--16.98--22.54--10.51--
Resonate Blends Inc16.47k-1.42m3.11m6.00------188.91-0.0178-0.01780.0002-0.02470.0237-------203.52-680.29-----593.02-78.88-8,597.33-12,895.26---0.46917.89---66.73-56.57-316.63------
ENDRA Life Sciences Inc0.00-9.89m3.11m21.00--0.8329-----1.26-1.260.000.33880.00----0.00-168.89-132.00-228.29-157.28------------0.00------23.67---19.46--
AccuStem Sciences Inc0.00-2.05m3.14m3.00---------0.1807-0.18070.00-0.18610.00----0.00-382.02--------------------------45.26------
AgriFORCE Growing Systems Ltd16.28k-13.34m3.19m7.00--0.3093--195.91-10.78-10.780.00390.3960.0009--0.4432,325.71-74.39-78.95-100.77-109.8616.58---81,946.25-243,182.500.8186-1.300.1913------8.85--48.61--
Optimus Healthcare Services Inc1.27m-7.79m3.20m17.00------2.53-0.1948-0.19480.0317-0.12910.2595--2.1674,453.53-159.79---2,228.37--77.90---615.77--0.1525-15.4121.18--------------
Livewire Ergogenics Inc67.98k-1.09m3.35m1.00------49.25-0.0061-0.00610.0003-0.00220.19791.742.8667,980.00-317.45-------113.70---1,604.38--0.1248-2.13----68.58---3.64------
Manuka Inc671.00k-1.14m3.36m4.00------5.01-0.0128-0.01280.0066-0.01242.410.941237.28167,750.00-410.43-463.75----88.08---170.04-732.150.0194-----------854.23------
Bio Path Holdings Inc0.00-13.96m3.36m10.00---------27.39-27.390.00-3.480.00----0.00-216.97-70.80-390.65-76.87---------------------15.94------
Atreca Inc0.00-97.76m3.37m90.00--0.313-----2.49-2.490.000.27150.00----0.00-98.54-44.99-116.19-48.05------------0.00------11.13---8.46--
Aditxt Inc4.03m-31.57m3.38m47.00------0.8389-100.82-100.820.4992--------85,739.79---192.78---321.5968.67---774.60-7,208.65---3.75-----30.90---18.11------
Avenue Therapeutics Inc0.00-7.18m3.41m3.00--0.7534-----39.36-39.360.004.810.00----0.00-123.08-186.91-1,045.52-287.70------------0.00-------192.15------
Seelos Therapeutics Inc1.97m-27.12m3.47m10.00------1.76-44.59-44.592.16-17.360.1449--2.24131,600.00-198.99-180.05---386.76-----1,373.61-9,612.88------------48.48------
Tharimmune Inc0.00-8.89m3.59m2.00--0.5099-----7.44-7.440.000.59790.00----0.00-130.60---173.40--------------0.00-------9.98------
Zyversa Therapeutics Inc0.00-105.53m3.60m7.00--0.3206-----1,791.54-1,791.540.0013.440.00----0.00-142.87---164.77-------------17,576.860.00-------340.15------
Data as of May 09 2024. Currency figures normalised to Manuka Inc's reporting currency: US Dollar USD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.